Related Experiment Video
Updated: Apr 3, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Human ABCB1 confers cells resistance to cytotoxic guanidine alkaloids from Pterogyne nitens
Kazuhiro Satake1, Megumi Tsukamoto1, Yuji Mitani1
1Department of Applied Biological Chemistry, Graduate School of Bioscience and Biotechnology, Chubu University, Kasugai, Japan.
Abstract:
Multidrug resistance (MDR) caused by human ABCB1 (P-glycoprotein/MDR1) is one of the major obstacles in chemotherapy. To understand the mechanism of MDR by ABCB1 and circumvent the MDR, in the present study, we established human ABCB1-expressing cells (Flp-In-293/ABCB1 cells) and examined the cytotoxic effects of four guanidine alkaloids from Pterogyne nitens (galegine, nitensidine A, pterogynidine and pterogynine) using Flp-In-293/Mock and Flp-In-293/ABCB1 cells. The activity of ABCB1 in Flp-In-293/ABCB1 cells were confirmed by typical substrates for ABCB1 (taxol and vinblastine) in MTT assay. Flp-In-293/ABCB1 cells were also resistant to the four guanidine alkaloids as well as taxol and vinblastine compared to Flp-In-293/Mock cells although the four guanidine alkaloids exhibited cytotoxicity against the two Flp-In-293 cells. Furthermore, the four guanidine alkaloids were also found to stimulate the ATPase activity of ABCB1 in ATPase assays. These results suggest that ABCB1 can confer the resistance to the cytotoxic guanidine alkaloids by transporting them.
Insights
Human ABCB1 (P-glycoprotein) confers multidrug resistance (MDR) by transporting guanidine alkaloids from Pterogyne nitens. This study reveals ABCB1
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- Multidrug resistance (MDR) mediated by human ABCB1 (P-glycoprotein/MDR1) significantly hinders chemotherapy efficacy.
- Understanding ABCB1's role in MDR is crucial for developing strategies to overcome treatment resistance.
Purpose of the Study:
- To investigate the mechanism by which ABCB1 confers resistance to four guanidine alkaloids from Pterogyne nitens.
- To assess the potential of these alkaloids as substrates for ABCB1 and their impact on ABCB1-mediated drug efflux.
Main Methods:
- Establishment of human ABCB1-expressing cells (Flp-In-293/ABCB1) and control cells (Flp-In-293/Mock).
- Cytotoxicity assays (MTT) to evaluate the effects of guanidine alkaloids and known ABCB1 substrates (taxol, vinblastine) on cell viability.
- ATPase assays to determine if the guanidine alkaloids stimulate ABCB1's intrinsic ATPase activity.
Main Results:
- ABCB1-expressing cells demonstrated resistance to the four guanidine alkaloids, galegine, nitensidine A, pterogynidine, and pterogynine, as well as to taxol and vinblastine, compared to control cells.
- The four guanidine alkaloids exhibited cytotoxicity against both cell lines, indicating inherent activity.
- Guanidine alkaloids were found to stimulate the ATPase activity of ABCB1, suggesting they are substrates.
Conclusions:
- Human ABCB1 confers resistance to cytotoxic guanidine alkaloids from Pterogyne nitens.
- ABCB1 actively transports these alkaloids, contributing to their reduced efficacy in the presence of ABCB1.
- These findings provide insights into overcoming MDR mediated by ABCB1 for chemotherapy applications.
More Related Videos
Related Concept Videos
ABC Transporters: Exporter
Physical Properties of Amines
GPCRs Regulate Adenylyl Cylase Activity
Treatment Resistant Cancers

